{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:25:45Z","timestamp":1789500345189,"version":"build-2803163510"},"reference-count":55,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Preeclampsia is a pregnancy-specific disease which is characterized by abnormal placentation, endothelial dysfunction, and systemic inflammation. Several studies have shown that the maternal immune system, which is crucial for maintaining the pregnancy by ensuring maternal-fetal-tolerance, is disrupted in preeclamptic patients. Besides different immune cells, immune checkpoint molecules such as the programmed cell death protein 1\/programmed death-ligand 1 (PD-1\/PD-L1 system) and the T-cell immunoglobulin and mucin domain-containing protein 3\/Galectin-9 (TIM-3\/Gal-9 system) are key players in upholding the balance between pro-inflammatory and anti-inflammatory signals. Therefore, a clear understanding about the role of these immune checkpoint molecules in preeclampsia is essential. This review discusses the role of these two immune checkpoint systems in pregnancy and their alterations in preeclampsia.<\/jats:p>","DOI":"10.3390\/medicina58020157","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T22:51:06Z","timestamp":1642719066000},"page":"157","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The Role of the Immune Checkpoint Molecules PD-1\/PD-L1 and TIM-3\/Gal-9 in the Pathogenesis of Preeclampsia\u2014A Narrative Review"],"prefix":"10.3390","volume":"58","author":[{"given":"Johanna","family":"Mittelberger","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstra\u00dfe 2, 86156 Augsburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Seefried","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstra\u00dfe 2, 86156 Augsburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Franitza","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstra\u00dfe 2, 86156 Augsburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Garrido","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstra\u00dfe 2, 86156 Augsburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Ditsch","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstra\u00dfe 2, 86156 Augsburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2623-3235","authenticated-orcid":false,"given":"Udo","family":"Jeschke","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstra\u00dfe 2, 86156 Augsburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Dannecker","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University Hospital Augsburg, Stenglinstra\u00dfe 2, 86156 Augsburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: Pathophysiology, challenges, and perspectives","volume":"124","author":"Rana","year":"2019","journal-title":"Circ. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1933719112450330","article-title":"Innate immunity, decidual cells, and preeclampsia","volume":"20","author":"Yeh","year":"2013","journal-title":"Reprod. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0897.2010.00836.x","article-title":"The immune system in pregnancy: A unique complexity","volume":"63","author":"Mor","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/aji.12805","article-title":"The possible role of CD8+\/V\u03b17.2+\/CD161++ T (MAIT) and CD8+\/V\u03b17.2+\/CD161lo T (MAIT-like) cells in the pathogenesis of early-onset pre-eclampsia","volume":"79","author":"Meggyes","year":"2018","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1038\/sj.emboj.7601146","article-title":"T-cell tolerance or function is determined by combinatorial costimulatory signals","volume":"25","author":"Nurieva","year":"2006","journal-title":"EMBO J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1095\/biolreprod.102.010058","article-title":"B7 family molecules are favorably positioned at the human maternal-fetal interface","volume":"68","author":"Petroff","year":"2003","journal-title":"Biol. Reprod."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/PGP.0000000000000305","article-title":"PD-L1 expression in human placentas and gestational trophoblastic diseases","volume":"36","author":"Veras","year":"2017","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Miko, E., Meggyes, M., Doba, K., Barakonyi, A., and Szereday, L. (2019). Immune Checkpoint Molecules in Reproductive Immunology. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00846"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10147-016-0958-0","article-title":"Basics of PD-1 in self-tolerance, infection, and cancer immunity","volume":"21","author":"Chikuma","year":"2016","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2009.00767.x","article-title":"PD-1 signaling in primary T cells","volume":"229","author":"Riley","year":"2009","journal-title":"Immunol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.20050019","article-title":"A critical role for the programmed death ligand 1 in fetomaternal tolerance","volume":"202","author":"Guleria","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/eji.200324228","article-title":"Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses","volume":"33","author":"Liang","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.179.8.5211","article-title":"A Link between PDL1 and T Regulatory Cells in Fetomaternal Tolerance","volume":"179","author":"Habicht","year":"2007","journal-title":"J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.4049\/jimmunol.1002031","article-title":"The Link between the PDL1 Costimulatory Pathway and Th17 in Fetomaternal Tolerance","volume":"187","author":"Riella","year":"2011","journal-title":"J. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jri.2008.12.001","article-title":"Maternal PD-1 regulates accumulation of fetal antigen-specific CD8+ T cells in pregnancy","volume":"80","author":"Taglauer","year":"2009","journal-title":"J. Reprod. Immunol."},{"key":"ref_18","first-page":"1","article-title":"Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancy","volume":"79","author":"Enninga","year":"2017","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.00086","article-title":"Elevated Soluble PD-L1 in Pregnant Women\u2019s Serum Suppresses the Immune Reaction","volume":"10","author":"Okuyama","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Meggyes, M., Miko, E., Szigeti, B., Farkas, N., and Szereday, L. (2019). The importance of the PD-1\/PD-L1 pathway at the maternal-fetal interface. BMC Pregnancy Childbirth, 19.","DOI":"10.1186\/s12884-019-2218-6"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Meggyes, M., Nagy, D.U., and Szereday, L. (2020). Investigation of the PD-1 and PD-L1 Immune Checkpoint Molecules Throughout Healthy Human Pregnancy and in Nonpregnant Women. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082536"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.humpath.2018.10.001","article-title":"Analysis of PD-L1 expression in trophoblastic tissues and tumors","volume":"84","author":"Lu","year":"2018","journal-title":"Hum. Pathol."},{"key":"ref_23","first-page":"1","article-title":"Immunosuppressive Protein Signatures Carried by Syncytiotrophoblast-Derived Exosomes and Their Role in Human Pregnancy","volume":"12","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/JLB.1A0420-012RR","article-title":"Trophoblast-secreted soluble-PD-L1 modulates macrophage polarization and function","volume":"108","author":"Zhang","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"van \u2019t Hof, L.J., Dijkstra, K.L., van der Keur, C., Eikmans, M., Baelde, H.J., Bos, M., and van der Hoorn, M.L.P. (2020). Decreased expression of ligands of placental immune checkpoint inhibitors in uncomplicated and preeclamptic oocyte donation pregnancies. J. Reprod. Immunol., 142.","DOI":"10.1016\/j.jri.2020.103194"},{"key":"ref_26","first-page":"2","article-title":"Maternal soluble PD-1 levels are significantly increased in women with preeclampsia","volume":"83","author":"Gu","year":"2019","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"97671","DOI":"10.18632\/oncotarget.18311","article-title":"Soluble PD-1 and PD-L1: Predictive and prognostic significance in cancer","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Meggyes, M., Miko, E., Lajko, A., Csiszar, B., Sandor, B., Matrai, P., Tamas, P., and Szereday, L. (2019). Involvement of the PD-1\/PD-L1 co-inhibitory pathway in the pathogenesis of the inflammatory stage of early-onset preeclampsia. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030583"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Morita, K., Tsuda, S., Kobayashi, E., Hamana, H., Tsuda, K., Shima, T., Nakashima, A., Ushijima, A., Kishi, H., and Saito, S. (2020). Analysis of TCR Repertoire and PD-1 Expression in Decidual and Peripheral CD8+ T Cells Reveals Distinct Immune Mechanisms in Miscarriage and Preeclampsia. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01082"},{"key":"ref_30","first-page":"1","article-title":"The PD-1\/PD-L1 inhibitory pathway is altered in pre-eclampsia and regulates T cell responses in pre-eclamptic rats","volume":"6","author":"Tian","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_31","first-page":"163","article-title":"Evaluation of exhausted regulatory t cells in preeclampsia","volume":"16","author":"Daraei","year":"2019","journal-title":"Iran. J. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/cmi.2017.70","article-title":"The altered PD-1\/PD-L1 pathway delivers the \u2018one-two punch\u2019 effects to promote the Treg\/Th17 imbalance in pre-eclampsia","volume":"15","author":"Zhang","year":"2018","journal-title":"Cell Mol. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Zhang, X., Du, N., Sun, H., Chen, L., Bao, H., Zhao, Q., Qu, Q., Ma, D., and Kwak-Kim, J. (2020). Immune checkpoint molecules on T cell subsets of pregnancies with preeclampsia and gestational diabetes mellitus. J. Reprod. Immunol., 142.","DOI":"10.1016\/j.jri.2020.103208"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/jcmm.12715","article-title":"Amniotic mesenchymal cells from pre-eclamptic placentae maintain immunomodulatory features as healthy controls","volume":"20","author":"Pianta","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2021.04.011","article-title":"The TIM3\/Gal9 signaling pathway: An emerging target for cancer immunotherapy","volume":"510","author":"Kandel","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.4049\/jimmunol.0803876","article-title":"Human Pregnancy Up-Regulates Tim-3 in Innate Immune Cells for Systemic Immunity","volume":"182","author":"Zhao","year":"2009","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Li, Y., Zhang, J., Zhang, D., Hong, X., Tao, Y., Wang, S., Xu, Y., Piao, H., Yin, W., and Yu, M. (2017). Tim-3 signaling in peripheral NK cells promotes maternal-fetal immune tolerance and alleviates pregnancy loss. Sci. Signal., 10.","DOI":"10.1126\/scisignal.aah4323"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Meggyes, M., Miko, E., Polgar, B., Bogar, B., Farkas, B., Illes, Z., and Szereday, L. (2014). Peripheral blood TIM-3 Positive NK and CD8+ T cells throughout pregnancy: TIM-3\/Galectin-9 interaction and its possible role during pregnancy. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092371"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41419-018-1251-0","article-title":"Blockade of CTLA-4 and Tim-3 pathways induces fetal loss with altered cytokine profiles by decidual CD4+T cells","volume":"10","author":"Wang","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/humrep\/dew019","article-title":"Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+T cells to induce Type 2 helper T cell (Th2) bias at the maternal\u2013fetal interface","volume":"31","author":"Wang","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e1738","DOI":"10.1038\/cddis.2015.112","article-title":"PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy","volume":"6","author":"Wang","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41419-019-1642-x","article-title":"The appropriate frequency and function of decidual Tim-3+CTLA-4+CD8+ T cells are important in maintaining normal pregnancy","volume":"10","author":"Wang","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_43","first-page":"1","article-title":"TIM-3 regulates innate immune cells to induce fetomaternal tolerance","volume":"23","author":"Chabtini","year":"2014","journal-title":"Bone"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1080\/14767058.2018.1526919","article-title":"T-cell immunoglobulin mucin-3 and galectin-9 levels in peripheral blood mononuclear cells predict fetal acidemia in twin pregnancies","volume":"33","author":"Sisti","year":"2020","journal-title":"J. Matern. Neonatal. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/cmi.2014.126","article-title":"The Galectin-9\/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancy","volume":"13","author":"Li","year":"2016","journal-title":"Cell Mol. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Sun, J., Yang, M., Ban, Y., Gao, W., Song, B., Wang, Y., Zhang, Y., Shao, Q., Kong, B., and Qu, X. (2016). Tim-3 Is Upregulated in NK Cells during Early Pregnancy and Inhibits NK Cytotoxicity toward Trophoblast in Galectin-9 Dependent Pathway. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0147186"},{"key":"ref_47","first-page":"1","article-title":"Tim-3 protects decidual stromal cells from toll-like receptor-mediated apoptosis and inflammatory reactions and promotes Th2 bias at the maternal-fetal interface","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1093\/humrep\/deaa223","article-title":"Newly characterized decidual Tim-3+Treg cells are abundant during early pregnancy and driven by IL-27 coordinately with Gal-9 from trophoblasts","volume":"35","author":"Hu","year":"2020","journal-title":"Hum. Reprod."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.placenta.2015.09.015","article-title":"Fetal gender specific expression of tandem-repeat galectins in placental tissue from normally progressed human pregnancies and intrauterine growth restriction (IUGR)","volume":"36","author":"Hutter","year":"2015","journal-title":"Placenta"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e21754","DOI":"10.1096\/fj.202100142R","article-title":"Tim-3\/CTLA-4 pathways regulate decidual immune cells-extravillous trophoblasts interaction by IL-4 and IL-10","volume":"35","author":"Li","year":"2021","journal-title":"FASEB J."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Miko, E., Meggyes, M., Bogar, B., Schmitz, N., Barakonyi, A., Varnagy, A., Farkas, B., Tamas, P., Bodis, J., and Szekeres-Bartho, J. (2013). Involvement of Galectin-9\/TIM-3 Pathway in the Systemic Inflammatory Response in Early-Onset Preeclampsia. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0071811"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejogrb.2015.08.022","article-title":"Upregulation of the Tim-3\/Gal-9 pathway and correlation with the development of preeclampsia","volume":"194","author":"Hao","year":"2015","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1007\/s43032-021-00675-3","article-title":"Involvement of the Tim-3 Pathway in the Pathogenesis of Pre-Eclampsia","volume":"28","author":"Wang","year":"2021","journal-title":"Reprod. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.placenta.2021.08.060","article-title":"The abnormal expression of Tim-3 is involved in the regulation of myeloid-derived suppressor cells and its correlation with preeclampsia","volume":"114","author":"Dong","year":"2021","journal-title":"Placenta"},{"key":"ref_55","first-page":"1","article-title":"Galectin-9 Alleviates LPS-Induced Preeclampsia-Like Impairment in Rats via Switching Decidual Macrophage Polarization to M2 Subtype","volume":"10","author":"Li","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/2\/157\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:04:45Z","timestamp":1760133885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/2\/157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["medicina58020157"],"URL":"https:\/\/doi.org\/10.3390\/medicina58020157","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]}}}